Sorafenib enhances graft-versus-leukemia activity through IL-18-mediated macrophage and NK cell crosstalk in FLT3-ITD acute myeloid leukemia
Cell Reports · 2026-10 · 45 (10) · 118083
DOI: 10.1016/j.celrep.2026.118083 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2026-10. Verfasst von Ruoyang Shao und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China; Clinical Medical Research Center of Hematology Dise…. Hauptthemen laut MEDLINE: Sorafenib, Macrophages, Leukemia, Myeloid, Acute, Killer Cells, Natural. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Key Technologies Research and Development Program, National Natural Science Foundation of China, Guangdong Provincial Natural Science Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China; Clinical Medical Research Center of Hematology Diseases of Guangdong Province, Guangzhou 510515, China.
- Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China; Clinical Medical Research Center of Hematology Diseases of Guangdong Province, Guangzhou 510515, China. Electronic addres…
- Department of Hematology, Peking University People's Hospital, Beijing 100044, China. Electronic address: ywyw3172@sina.com.
Förderung
- Key Technologies Research and Development Program
- National Natural Science Foundation of China
- Guangdong Provincial Natural Science Foundation
- China Postdoctoral Science Foundation
Zitieren
APA
Shao, R., Chi, P., Fan, Z., Bai, Y., Jiang, Z., Dai, F., Zhang, T., Qiu, G., Huang, F., Xu, N., Yang, X., Li, K., Zhong, Y., Jin, H., Sun, J., Xu, X., Wang, Y., Liu, Q., & Xuan, L. (2026). Sorafenib enhances graft-versus-leukemia activity through IL-18-mediated macrophage and NK cell crosstalk in FLT3-ITD acute myeloid leukemia. Cell Reports, 45(10), 118083. https://doi.org/10.1016/j.celrep.2026.118083
Vancouver
Shao R, Chi P, Fan Z, Bai Y, Jiang Z, Dai F, et al. Sorafenib enhances graft-versus-leukemia activity through IL-18-mediated macrophage and NK cell crosstalk in FLT3-ITD acute myeloid leukemia. Cell Reports. 2026;45(10):118083. doi:10.1016/j.celrep.2026.118083
BibTeX
@article{Shao2026,
author = {Shao, Ruoyang and Chi, Peiru and Fan, Zhiping and Bai, Yuxin and Jiang, Zhonghui and Dai, Fang and Zhang, Tian and Qiu, Guo and Huang, Fen and Xu, Na and Yang, Xiaofeng and Li, Kejing and Zhong, Yueyang and Jin, Hua and Sun, Jing and Xu, Xi and Wang, Yu and Liu, Qifa and Xuan, Li},
title = {Sorafenib enhances graft-versus-leukemia activity through IL-18-mediated macrophage and NK cell crosstalk in FLT3-ITD acute myeloid leukemia},
journal = {Cell Reports},
year = {2026},
volume = {45},
number = {10},
pages = {118083},
doi = {10.1016/j.celrep.2026.118083}
}
EUVIMED